Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry.

Péter Tajti(Southwestern Medical Center), Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), Raja Hatem(Columbia University), Imre Ungi(University of Szeged), Subhash Banerjee(Baylor University Medical Center), Judit Karácsonyi(University of Utah), Bavana V. Rangan(Minneapolis Heart Institute Foundation), James W. Choi(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Catalin Toma(University of Pittsburgh Medical Center), Farouc A. Jaffer(Massachusetts General Hospital), Aris Karatasakis, Barbara A. Danek, Dimitri Karmpaliotis(Columbia University), Ziad A. Ali(St. Francis Hospital), Ajay J. Kirtane(Columbia University Irving Medical Center), Jeffrey W. Moses(Good Samaritan University Hospital), Santiago García(University of Minnesota), Barry F. Uretsky(Central Arkansas Veterans Healthcare System), Khaldoon Alaswad(Ford Motor Company (United States)), Manish Parikh, Robert W. Yeh(Beth Israel Deaconess Medical Center), Anthony Doing(Banner McKee Medical Center), Mitul Patel(University of California San Diego), Ehtisham Mahmud(Cardiovascular Institute of the South)
PubMed
March 1, 2018
Cited by 28

Related Papers

Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
|The Lancet|2015|1.8k
Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
|New England Journal of Medicine|2012|1.3k